Literature DB >> 21852454

Human sperm binding is mediated by the sialyl-Lewis(x) oligosaccharide on the zona pellucida.

Poh-Choo Pang1, Philip C N Chiu, Cheuk-Lun Lee, Lan-Yi Chang, Maria Panico, Howard R Morris, Stuart M Haslam, Kay-Hooi Khoo, Gary F Clark, William S B Yeung, Anne Dell.   

Abstract

Human fertilization begins when spermatozoa bind to the extracellular matrix coating of the oocyte, known as the zona pellucida (ZP). One spermatozoan then penetrates this matrix and fuses with the egg cell, generating a zygote. Although carbohydrate sequences on the ZP have been implicated in sperm binding, the nature of the ligand was unknown. Here, ultrasensitive mass spectrometric analyses revealed that the sialyl-Lewis(x) sequence [NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAc], a well-known selectin ligand, is the most abundant terminal sequence on the N- and O-glycans of human ZP. Sperm-ZP binding was largely inhibited by glycoconjugates terminated with sialyl-Lewis(x) sequences or by antibodies directed against this sequence. Thus, the sialyl-Lewis(x) sequence represents the major carbohydrate ligand for human sperm-egg binding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852454     DOI: 10.1126/science.1207438

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  92 in total

1.  Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases.

Authors:  Matthew S Macauley; Britni M Arlian; Cory D Rillahan; Poh-Choo Pang; Nikki Bortell; Maria Cecilia G Marcondes; Stuart M Haslam; Anne Dell; James C Paulson
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

2.  Novel biallelic loss-of-function variants in ZP1 identified in an infertile female with empty follicle syndrome.

Authors:  Mohan Liu; Ying Shen; Xueguang Zhang; Xiang Wang; Dan Li; Yan Wang
Journal:  J Assist Reprod Genet       Date:  2020-06-16       Impact factor: 3.412

Review 3.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 4.  The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited.

Authors:  Gary F Clark
Journal:  Mol Hum Reprod       Date:  2013-09-15       Impact factor: 4.025

5.  Characterization of Isomeric Glycans by Reversed Phase Liquid Chromatography-Electronic Excitation Dissociation Tandem Mass Spectrometry.

Authors:  Yang Tang; Juan Wei; Catherine E Costello; Cheng Lin
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-13       Impact factor: 3.109

6.  Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.

Authors:  Petr Pompach; Zuzana Brnakova; Miloslav Sanda; Jing Wu; Nathan Edwards; Radoslav Goldman
Journal:  Mol Cell Proteomics       Date:  2013-02-06       Impact factor: 5.911

Review 7.  The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins.

Authors:  Fanqi Jin; Fengshan Wang
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

Review 8.  Glycan evolution in response to collaboration, conflict, and constraint.

Authors:  Stevan A Springer; Pascal Gagneux
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  Identification of the binding roles of terminal and internal glycan epitopes using enzymatically synthesized N-glycans containing tandem epitopes.

Authors:  Zhigang Wu; Yunpeng Liu; Cheng Ma; Lei Li; Jing Bai; Lauren Byrd-Leotis; Yi Lasanajak; Yuxi Guo; Liuqing Wen; He Zhu; Jing Song; Yanhong Li; David A Steinhauer; David F Smith; Baohua Zhao; Xi Chen; Wanyi Guan; Peng George Wang
Journal:  Org Biomol Chem       Date:  2016-11-29       Impact factor: 3.876

Review 10.  Biological functions of fucose in mammals.

Authors:  Michael Schneider; Esam Al-Shareffi; Robert S Haltiwanger
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.